2.2. Selective SK2 Inhibition Using HWG-35D Improves Severity of Psoriasis-Like Skin Lesions in a Murine Model of Psoriasis With the Dosage of 25 μG/40 μL Surfactant. Here, SPHK2 is linked to psoriasis.